Sodium Phenylacetate And Sodium Benzoate Injection
Product Images NDC 72266-236

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sodium Phenylacetate And Sodium Benzoate (NDC 72266-236). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fosun Pharma Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton Label (Carton Label)

Carton Label (Carton Label)
Packaging label for Sodium Phenylacetate and Sodium Benzoate Injection 10% / 10%, intravenous use, 20 mL single-dose vial. Label includes warnings about administration through a central venous catheter, dilution instructions with dextrose injection, storage conditions, and distribution by Fosun Pharma USA Inc. Barcode is also present.*
FDA Label Image

Figure 1 (Chemical Structure)

Figure 1 (Chemical Structure)
Chemical structure diagram showing sodium phenylacetate and sodium benzoate, the active ingredients in this injection product by Fosun Pharma USA Inc.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A biochemical pathway diagram depicting the urea cycle and related metabolic steps. It includes enzymes such as carbamyl phosphate synthetase (CPS), ornithine transcarbamylase (OTC), argininosuccinate synthetase (ASS), argininosuccinate lyase (ASL), arginase (ARG), and N-acetylglutamate synthetase (NAGS). The diagram shows reactions involving metabolites like glutamine, carbamyl phosphate, citrulline, argininosuccinate, arginine, ornithine, and hippurate, highlighting the enzymatic conversions and pathways for nitrogen disposal and phenylacetylglutamine formation with urine excretion.*
FDA Label Image

Table 1 (Table 1 Revised)

Table 1 (Table 1 Revised)
Table presenting dosage and administration guidelines for Sodium Phenylacetate and Sodium Benzoate Injection combined with Arginine HCl Injection for different patient populations (0 to 20 kg and over 20 kg) with CPS and OTC deficiency and ASS and ASL deficiency. Dosage values are given per kg or square meter for loading and maintenance phases, with infusion solution components and corresponding drug dosages specified.*
FDA Label Image

Table 2 (Table 2)

Table 2 (Table 2)
A data table listing adverse reactions occurring in 3% or more of patients treated with Sodium Phenylacetate and Sodium Benzoate Injection. The table details the number and percentage of patients experiencing various adverse events, grouped by system disorders such as blood and lymphatic, cardiac, gastrointestinal, nervous system, psychiatric, renal, respiratory, skin, and vascular disorders among 316 patients.*
FDA Label Image

Table 3 (Table 3)

Table 3 (Table 3)
A data table titled 'Baseline Characteristics and Diagnoses of Study Population' summarizing patient demographics (gender and age groups) and enzyme deficiencies in a population of 316 patients. The table includes percentages and counts for males and females, age ranges, and various enzyme deficiencies with definitions provided below the table.*
FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)
Label for Sodium Phenylacetate and Sodium Benzoate Injection, 10%/10% strength, for intravenous use only. The label includes warnings about administration through a central venous catheter, dilution requirements before intravenous use, and storage instructions. It is a 20 mL single-dose vial distributed by Fosun Pharma USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.